About
A key goal of ECTRIMS’ mission is to be actively involved in coordinating initiatives in research and clinical care in Europe and worldwide.
MS Clinical Trials and Guidelines
Clinical Trials and Guidelines
Recent Guidelines
Consensus on Vaccination in People with Multiple Sclerosis
The first European consensus on vaccination in people with MS (pwMS) proposes the best vaccination strategy according to current evidence and expert knowledge, with the goal of homogenizing the immunization practices in pwMS.
Guideline on the Pharmacological Treatment of People with MS
This joint ECTRIMS-EAN guideline is a reference tool to aid professionals in MS treatment decisions and is aimed at enabling homogeneity of treatment decisions across Europe.
International Advisory Committee on Clinical Trials in Multiple Sclerosis
The International Advisory Committee on Clinical Trials in Multiple Sclerosis is a global body sponsored by ECTRIMS and the US National Multiple Sclerosis Society (NMSS). The Committee works to provide perspective and guidance in areas of interest to planning and implementing clinical trials for new agents for the treatment of multiple sclerosis.
Registries for MS Clinical Trials
A number of governmental not-for-profit and for-profit organisations provide useful and easily accessible registries for recent and ongoing clinical trials.
- Clinicaltrials.gov is a registry of worldwide clinical trials run by the United States Library of Medicine.
- The Multiple Sclerosis International Federation (MSIF) provides a list of MS databases and registries in Europe and Australia and general information about clinical trial design for patients interested in participating in a study.